MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)

    J. Zitser, A. Bar David, H. Shabtai, A. Ezra, M. Brozgol, C. Peretz, A. Rozenberg, T. Herman, G.T. Setbbins, C.G. Goetz, B.C. Tilley, S.T. Luo, L. Wang, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To assess the clinimetric properties of the Hebrew version of the MDS-UPDRS. Background: The Unified Parkinson's disease Rating Scale (UPDRS) is a rating scale…
  • 2016 International Congress

    Dystonia-deafness syndrome caused by beta -actin gene mutation and the effect of pallidal deep brain stimulation

    H. Eggink, M.E. van Egmond, M.C. Schönherr, C.C. Verschuuren-Bemelmans, T.J. de Koning, M.J.C. van Dijk, M.A.J. Tijssen (Groningen, Netherlands)

    Objective: To report on two patients with dystonia-deafness syndrome associated with a mutation in the beta actin gene and a positive effect of pallidal deep…
  • 2016 International Congress

    Multicentre retrospective chart review of patients treated with incobotulinumtoxinA to evaluate sustained efficacy and tolerability in converted and de-novo conditions

    M.S. Jog, R.M. Jog, A. Tewari, D. Hobson, D. Stewart, D. King (London, ON, Canada)

    Objective: This study aimed to determine whether IncobotulinumtoxinA (IBTX) provides sustained efficacy as a treatment modality patients in both de-novo patients and patients converted from…
  • 2016 International Congress

    Botulinum toxin A injections changes sensorimotor network activations in cervical dystonia to state more related to physiological condition

    M. Nevrly, P. Hlustik, P. Otruba, P. Hok, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To evaluate botulinum toxin A (BoNT-A) effectiveness on network in sensorimotor circuits. Background: Involvement of many cerebellar structures, such basal ganglia, thalamus, cerebellum, premotor…
  • 2016 International Congress

    Frequency and types of dystonia in Wilson’s disease patients

    K. Dziezyc, T. Litwin, G. Chabik, A. Czlonkowska (Warsaw, Poland)

    Objective: To establish the frequency and types of dystonia in our cohort of Wilson's disease patients. Background: Wilson's disease (WD) belongs to movement disorders with…
  • 2016 International Congress

    In-vivo free-water imaging and functional connectivity in a knock-in mouse model of DYT1 dystonia

    J.C. DeSimone, M. Febo, P. Shukla, E. Ofori, L.M. Colon-Perez, Y. Li, D.E. Vaillancourt (Gainesville, FL, USA)

    Objective: To examine in-vivo functional connectivity and free-water diffusion imaging in dystonic mutant Tor1a knock-in (DYT1) and wild-type (WT) control mice. We test the hypothesis…
  • 2016 International Congress

    Pallidal deep brain stimulation improves dystonia in Woodhouse-Sakati syndrome

    J.Y. Chen, J.L. Ostrem, B. Lee, P. Starr, A. Viehoever (San Francisco, CA, USA)

    Objective: To describe a patient with a rare genetic disorder, Woodhouse-Sakati Syndrome, treated with deep brain stimulation (DBS) for dystonia. Background: Woodhouse-Sakati Syndrome (WSS) is…
  • 2016 International Congress

    Sensorimotor gray matter changes in professional brass players with and without Embouchure dystonia

    T.A. Mantel, C. Dresel, E. Altenmüller, A. Jochim, G. Gora-Stahlberg, C. Zimmer, B. Haslinger (Munich, Germany)

    Objective: To investigate patterns of gray matter alterations in professional brass musicians with embouchure dystonia (ED) in relation to healthy professional brass musicians and to…
  • 2016 International Congress

    Functional characterization of the upstream start codon in the GCH1 gene

    L.C. Jones, E. Davila, L.K. Goode, P.G. Bhide, I. Armata (Tallahassee, FL, USA)

    Objective: To examine (1) the -22C > T point mutation which introduces a premature start codon upstream of the normal open reading frame (ORF) of…
  • 2016 International Congress

    Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis

    R.E. Marques, G.S. Duarte, F.B. Rodrigues, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

    Objective: To compare the effects of botulinum toxin type A (BtA) versus placebo in blepharospasm. Background: This is an update of a Cochrane systematic review.…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • An atypical and interesting feature of Parkinson´s disease
      • A Case of Pregabalin induced Parkinsonism
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley